A Five-Year Data in Descriptive Study of Systemic and Ocular Risk Factors of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) and The Correlation to The Clinical Condition
Article Sidebar
-
NAION, risk factors, hypertension, obesity, diabetes melitus, smoking, dyslipidemia, hypercoagulable state, ardiovascular and stroke
Abstract
Purpose: To acknowledge the demographic, clinical characteristic and the systemic and ocular risk factors in patients with Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) in 2012-2017 in Cipto Mangunkusumo Hospital.
Methods: Retrospective descriptive study using the medical record data of 272 patients with NAION in the past 5 years (2012-2017).
Results: In the past 5 years, most of the patient’s initial visit visual acuity was <3/60, most patient had 2-3 systemic risk factors, the most frequent risk factors were hypertension (73.9%), obesity(63.5.%), diabetes mellitus (54.6%), smoking habit (54.5%), dyslipidaemia (46%), hypercoagulable state (19%), history of cardiovascular disease (10.3%) and stroke (7.2%). The risk factors were similar in age range ? 50 or bellow. Based on the initial visit time, most of the patient came to CM hospital in average 15.16 (SD±38.3) weeks.
Conclusion: This descriptive study showed classic demographic characteristic of NAION cases. Obesity as the second highest probable risk factor is rarely mention in the other studies. Should future detailed studies be done
Full text article
References
Atkins EJ, Bruce BB, Newman NJ, Biousse V. Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy. Survey of Ophthalmology. 2010:55(1):47-63.
Katz DM, Trobe JD. Is there treatment for nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2015;26(6):458–63.
Cestari DM, Gaier ED, Bouzika P, Blachley TS, De Lott LB, Rizzo JF, et al. Demographic, Systemic, and Ocular Factors Associated with Nonarteritic Anterior Ischemic Optic Neuropathy.Ophthalmology. 2016;123(12):2446–55.
Lestari M. Karakteristik Pasien Nonarteritik anterior Iskemik Optik Neuropati di RSUP dr.Ciptomangunkusumo periode Juni 2006-Juni 2011. Universitas Indonesia. 2011.
Aritonang YS. Karakteristik faktor risiko pasien non arteritik anterior iskemik optik neuropati di divisi Neuro-oftalmologi Departemen Mata RSUP dr. Cipto Mangunkusumo periode Januari 2012-Desember 2014. Universitas Indonesia. 2015.
Ischaemic optic neuropathy decompression trial. characteristic of patients with nonarteritic anterior ischemic optic neuropathy eligible for the ischemic optic neuropathy decompression trial. Archives of ophthalmology. 1996;114:1366-74.
Arnold AC, Costa RM, Dumitrascu OM. The spectrum of optic disc ischemia in patients younger than 50 years (an Amercian Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2013;111:93–118.
Kim DH, Shin GR, Choi YJ. Risk Factors for Non-arteritic Anterior Ischaemic Optic Neuropathy in a Korean Population. Neuro-Ophthalmology. 2017;41(2):68–75.
Berry S, Lin W, Sadaka A, Lee A. Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management. Eye Brain. 2017;Volume 9:23–8
Chan JW. Ischemic optic neuropathies. In: Optic Nerve Disorders: Diagnosis and Management. 2014.
Chen J. Trying to Understand Nonarteritic Anterior Ischemic Optic Neuropathy through Big Data. Ophthalmology 2016;123(12):2442– 3
Duman R, Yavas GF, Veliyev I, Dogan M, Duman R. Structural changes of macula and optic disk of the fellow eye in patients with nonarteritic anterior ischemic optic neuropathy. Int Ophthalmol. 2018
Preechawat P, Bruce BB, Newman NJ, Biousse V. Anterior Ischemic Optic Neuropathy in Patients Younger than 50 Years. Am J Ophthalmol. 2007;144(6):953-60
Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. Journal of Neuro Ophthalmology. 2003 ; 23 (2) :157-63
Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye. 2015;29(1):65–79
Tarantini A, Faraoni A, Menchini F, Lanzetta P. Bilateral simultaneous nonarteritic anterior ischemic optic neuropathy after ingestion of Sildenafil for erectile dysfunction. Case Rep Med. 2012
Gundogan FC, Guven S, Yolcu U, Sari S, Sobaci G. Bilateral simultaneous nonarteritic anterior ischaemic optic neuropathy: Case report. Neuro-Ophthalmology. 2013;37(5):214-9
Bawazir A, Gharebaghi R, Hussein A, Hazabbah Wan Hitam W. Non-arteritic anterior ischaemic optic neuropathy in Malaysia: a 5 years review. Int J Ophthalmol. 2011;4(3):272– 4
Hayreh SS. Ischemic optic neuropathy. Progress in Retinal and Eye Research. 2009:28(1):34-62
Xiao Y-Y, Wei W-B, Wang Y-X, Lu A-D, Chen S-H, Song L, et al. Systemic-Related Factors of Nonarteritic Anterior Ischemic Optic Neuropathy. Chin Med J. 2018;131 (19):2357.
Chen T, Song D, Shan G, Wang K, Wang Y, Ma J, et al. The Association between Diabetes Mellitus and Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis. PLoS One. 2013;8(9):1–7.
Sharma S, Kwan S, Fallano KA, Wang J, Miller NR, Subramanian PS. Comparison of Visual Outcomes of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients with and without Diabetes Mellitus. Ophthalmology. 2017;124(4):450–5
Talks SJ, Chong NHV, Gibson JM, Dodson PM. Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy. Eye. 1995;9(1):85-8
Deramo VA, Sergott RC, Augsburger JJ, Foroozan R, Savino PJ, Leone A. Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients. Ophthalmology. 2003;110(5):1041-6
Zotz RB, Finger C, Scharf RE, Unsöld R. Associations between thrombophilic risk factors and determinants of atherosclerosis and inflammation in patients with non-arteritic anterior ischaemic optic neuropathy. Hamostaseologie. 2016;36(1):46-54
Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy: A case-control study of potential risk factors. Arch Ophthalmol. 1997;115(11):1403-7
Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic Risks and Severity of Obesity in Children and Young Adults. N Engl J Med. 2015;373(14):1307-17
Wauters M, Considine R V., Van Gaal LF. Human leptin: From an adipocyte hormone to an endocrine mediator. European Journal of Endocrinology. 2000.;143(3):293-311
Radovanovic CAT, Santos LA dos, Carvalho MD de B, Marcon SS. Arterial Hypertension and other risk factors associated with cardiovascular diseases among adults. Rev Lat Am Enfermagem. 2014;2(4):547-3
Gunes A, Yigit M, Tok L, Tok O. Neutrophil to Lymphocyte Ratio in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy. Korean J Ophthalmol. 2017;31(2):159–64.
Nakashima MO, Rogers HJ. Hypercoagulable states: An algorithmic approach to laboratory testing and updatee on monitoring of direct oral anticoagulants. Blood Res. 2014;49(2):85–9
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
